Incidence and mortality rates of Guillain‐Barré syndrome in Serbia-Reference-Cited by-同舟云学术

Incidence and mortality rates of Guillain‐Barré syndrome in Serbia

Published:2020-09-15 Issue:4 Volume:25 Page:350-355
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:J Peripher Nerv Syst

Author:

Stojanov Aleksandar¹^ORCID,Berisavac Ivana²³,Bozovic Ivo²,Arsenijevic Mirjana²,Lukic‐Rajic Sonja⁴,Petrovic Milutin⁵,Stojiljkovic‐Tamas Olivera²,Jovin Zita⁴,Djordjevic Gordana¹⁶,Jovanovic Dejana²³,Stojanovic Miroslav⁵,Martic Vesna⁷,Basta Ivana²³,Peric Stojan²³^ORCID

Affiliation:

1. Neurology Clinic Clinical Center Nis Nis Serbia

2. Neurology Clinic Clinical Center of Serbia Belgrade Serbia

3. Faculty of Medicine University of Belgrade Belgrade Serbia

4. Neurology Clinic Clinical Center of Vojvodina Novi Sad Serbia

5. Neurology Clinic Clinical Center Kragujevac Kragujevac Serbia

6. Faculty of Medicine University of Nis Nis Serbia

7. Neurology Clinic Military Medical Academy Belgrade Serbia

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jns.12412

Reference48 articles.

1. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis

2. Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis

3. Effect of rehabilitation on mortality of patients with Guillain‐Barre syndrome: a propensity matched analysis using nationwide database;Inokuchi H;Eur J Phys Rehabil Med,2014

4. The prognosis and main prognostic indicators of Guillain–Barré syndrome: a multicenter prospective study of 297 patients;The Italian Guillain–Barré syndrome Study Group;Brain,1996

5. Prospective study of clinical epidemiology of Guillain–Barré syndrome in Harbin, China

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VX-509 (Decernotinib)-modified tolerogenic dendritic cells alleviate experimental autoimmune neuritis by promoting Th17/Treg rebalance;International Immunopharmacology;2024-09

2. Current status of Guillain–Barré syndrome (GBS) in China: a 10-year comprehensive overview;Reviews in the Neurosciences;2023-05-08

3. Downregulation of LKB1/AMPK Signaling in Blood Mononuclear Cells Is Associated with the Severity of Guillain–Barre Syndrome;Cells;2022-09-16

4. Etiological profile of peripheral neuropathies in an academic hospital in southern Morocco;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2022-08-20

5. Nursing Care of Patient with Guillain-Barré Syndrome According to Gordon's Functional Health Patterns Model: A Case Report;Sağlık Akademisi Kastamonu;2022-06-18